The global brain mapping instruments market size was valued at USD 1.49 billion in 2018 and is anticipated to grow at a CAGR of 5.8%. Rising adoption of new technologies, increasing health concerns, and increasing prevalence of neurological diseases are driving the market growth.
Researchers use a variety of brain mapping instruments to study the brain such as Magnetic Resonance Imaging (MRI), which is the most prominent neuroimaging technology to track the critical functioning of the brain. It tracks changes in the blood flow and oxygen levels to track brain activity. Another instrument is Electroencephalography (EEG) which records electrical waves of the brain to detect abnormal activities such as sleep disorders and seizures. The usage of these instruments helps surgeons in diagnosing and taking follow-up for the treatment of brain diseases and thus, increasing usage of these devices is driving the market growth.
The adoption of the latest technologies is primarily driving market growth. It includes Echo Planner Imaging (EPI) which is regarded as a faster MRI technique that can acquire MR images in only a fraction of a second. The use of EPI has resulted in technical advancement regarding clinical diagnoses such as the evaluation of stroke and other brain disorders. EPI offers benefits such as it can be performed by using single or multiple shots or pulse leading to the increasing demand for EPI, thus, contributing to the market’s growth.
An increasing number of patients suffering from neurological diseases is contributing to the brain mapping instruments market growth. One of the most common neurodegenerative diseases is Alzheimer’s Disease (AD) which is caused by abnormal function connectivity among the nodes of interconnected brain regions. Brain diseases include stroke, infections, trauma, and seizures. According to the U.S. Department of Health and Human Services, AD is the sixth leading cause of death in the U.S. and the most common cause of dementia among the geriatric population. Thus, increasing neurological diseases as well as improved infrastructure, and rising health concerns among different parts of the world is driving the market growth.
Computed Axial Tomography (CAT) dominated the market owing to its usage in X-ray procedures. CAT scans are basically performed to define the internal structure of the human body so that doctors can treat the patients accurately. It helps doctors to visualize small nodules and tumors that a normal X-ray cannot depict. It also generates 3D images of the internal organs of the body. Thus, its special characteristics such as painless procedures, make the machine reliable for the patient which further leads to drive the market growth.
The electroencephalography (EEG) segment is expected to grow at the highest CAGR over the forecast period owing to its features such as detecting brain disorders such as epilepsy and seizures, through diagnosing imaging techniques. It’s a diagnosing procedure that helps in determining changes in the electrical activity of the brain. Thus, due to its faster application procedure in detecting various brain disorders, it is driving the market’s growth.
North America dominated the market owing to the increasing prevalence of neurological diseases, rising adoption of technological advancements, and improved healthcare infrastructure in the U.S. Increasing prevalence of neurological diseases such as Alzheimer’s Disease (AD) is driving the market growth. According to the Michigan Alzheimer’s Disease Core Center, deaths from AD has been increased by 123%, between 2000 to 2015. AD is the most common cause of dementia among the geriatric population which causes loss of cognitive functioning such as reasoning, thinking, and remembering. It ranges from the mildest to the most severe stage due to which the patient gets completely dependent on others. Thus, increasing neurological diseases are anticipated to drive market growth.
Asia Pacific is expected to grow at the highest CAGR over the forecast period due to rising health concerns and increased adoption of the latest technology. According to the NCBI, neuroimaging studies of brain anatomy and cognitive functioning have been increasing due to the rising incidence of neurological diseases in the region. New techniques have also been adopted to treat patients suffering from brain diseases such as Echo Planar Imaging (EPI). EPI is the fast MRI technique that can acquire MR images in a fraction of the time. Thus, increasing brain diseases and the adoption of the latest technology in the region have led to an increase the market growth.
A few of the major players in the industry are GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Siemens Healthcare Private Limited, Medtronic, and Advanced Brain Monitoring, Inc. These key market players are focusing on the launch of innovative types of brain mapping instruments, growth strategies, and technological advancements.
For instance, in November 2018, Siemens Healthineers and Prism Clinical Imaging announced their partnership wherein, the Prism Clinical Imaging will deliver their brain mapping capabilities through their imaging capabilities in the digital marketplace. These advancements are anticipated to boost the market growth over the forecast period.
Market size value in 2020
USD 1.7 billion
Revenue forecast in 2026
USD 2.33 billion
CAGR of 5.8% from 2019 to 2026
Base year for estimation
2015 - 2017
2019 - 2026
Revenue in USD million and CAGR from 2019 to 2026
Revenue forecast, company share, competitive landscape, growth factors and trends
Product type, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; UK; Germany; France; Italy; Spain; Russia; Japan; China; India; Australia; South Korea; Singapore; Brazil; Mexico; Argentina; Colombia; South Africa; Saudi Arabia; UAE
Key companies profiled
Medtronic; GENERAL ELECTRIC COMPANY; Koninklijke Philips N.V.; Siemens Healthcare Private Limited; Advanced Brain Monitoring, Inc
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global brain mapping instruments market report on the basis of product type and region:
Product Type Outlook (Revenue, USD Million, 2015 - 2026)
Computed Axial Tomography (CAT)
Positron Emission Tomography (PET)
Functional Near-Infrared Spectroscopy (fNIRS)
Functional Magnetic Resonance Imaging (fMRI)
Regional Outlook (Revenue, USD Million, 2015 - 2026)
Middle East and Africa (MEA)
b. The global brain mapping instruments market size was estimated at USD 1.6 billion in 2019 and is expected to reach USD 1.7 billion in 2020.
b. The global brain mapping instruments market is expected to grow at a compound annual growth rate of 5.8% from 2019 to 2026 to reach USD 2.3 billion by 2026.
b. North America dominated the brain mapping instruments market with a share of 38.08% in 2019. This is attributable to technological advancement, and rising health concerns in the region.
b. Some of the key players operating in the brain mapping instruments market include Medtronic, GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V., Siemens Healthcare Private Limited, and Advanced Brain Monitoring, Inc.
b. Key factors that are driving the market growth include increasing incidence of neurological diseases, technological advancements, and rise in the geriatric population.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."